Abstract The objective was to investigate the effect of kinsenoside (Kin) treatments on macrophage polarity and evaluate the resulting protection of chondrocytes to attenuate osteoarthritis (OA) progression. RAW264.7 macrophages were polarized to M1/M2 subtypes then administered with different concentrations of Kin. The polarization transitions were evaluated with quantitative real-time polymerase chain reaction (qRT-PCR), confocal observation and flow cytometry analysis. The mechanism of Kin repolarizing M1 macrophages was evaluated by Western blot. Further, macrophage conditioned medium (CM) and IL-1β were administered to chondrocytes. Micro-CT scanning and histological observations were conducted in vivo on anterior cruciate ligament transection (ACLT) mice with or without Kin treatment. We found that Kin repolarized M1 macrophages to the M2 phenotype. Mechanistically, Kin inhibited the phosphorylation of IκBα, which further reduced the downstream phosphorylation of P65 in nuclear factor-κB (NF-κB) signaling. Moreover, Kin inhibited mitogen-activated protein kinases (MAPK) signaling molecules p-JNK, p-ERK and p-P38. Additionally, Kin attenuated macrophage CM and IL-1β-induced chondrocyte damage. In vivo, Kin reduced the infiltration of M1 macrophages, Abbreviations: AP-1, activator protein-1; Arg-1, arginase-1; BV, bone volume; BV/TV, bone volume/total tissue volume; C/EBP β, CCAAT/enhancerbinding protein β; CM, conditioned medium; DMEM, Dulbecco's minimum essential medium; GA, gouty arthritis; H&E, hematoxylin & eosin; HUVECs, human umbilical vein endothelial cells; IFN-γ, interferon-γ; iNOS, inducible nitric oxide synthase; IRF4, interferon regulatory factor 4; Kin, kinsenoside; LPS, lipopolysaccharides; MAPK, mitogen-activated protein kinases; MSU, monosodium urate; NF-κB, nuclear factor-κB; NSAIDs, non-steroidal antiinflammatory drugs; OA, osteoarthritis; OARSI, Osteoarthritis Research Society International; PPARγ, peroxisome proliferator-activated receptor γ; RA, rheumatoid arthritis; ROS, reactive oxygen species; S&F, safranin O-fast green; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness; TLRs, toll-like receptors; TNF-α, tumor necrosis factor-α n Corresponding authors. Tel.: +86 21 53315397; fax: +86 21 63137020. E-mail addresses: betterchiao@sjtu.edu.cn (Han Qiao), ttt@sjtu.edu.cn (Tingting Tang). † These authors made equal contributions to this work.
Introduction
As the most prevalent chronic musculoskeletal disease, osteoarthritis (OA) is characterized by the progressive degeneration of articular cartilage 1 and afflicts patients with significantly increased joint disability 2 . Numerous influential factors contribute to the slow devastation of cartilage in OA including synovial inflammation, subchondral remodeling and macrophage activation [3] [4] [5] [6] . Therefore, apart from the joint replacement surgery that is normally definitive treatment for OA patients in the advanced or end-stage 7 , conservative pharmacological treatments such as non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to relieve articular inflammation 8 . However, the deployment of NSAIDs is largely restrained because of the inevitable side effects. Hence, further exploration of novel therapeutic targets in OA for the development of more effective treatment strategies is imperative.
Macrophages actively participate in the pathophysiological processes of various chronic bone diseases such as gouty arthritis (GA), rheumatoid arthritis (RA) and OA [9] [10] [11] [12] . Macrophages play important roles in inflammation reactions that are crucial for the rehabilitation processes of musculoskeletal tissues 13, 14 , immune defense and tissue repair 9 . Macrophages can be polarized to M1/ M2 phenotypes according to the microenvironment. Specifically, M1 macrophages are classically activated by the stimulation of toll-like receptors (TLRs) through bacterial lipopolysaccharides (LPS) and the cytokine interferon-γ (IFN-γ) 15 . M1 macrophages have high secretion of pro-inflammatory cytokines, including IL-1β, IL-6, tumor necrosis factor-α (TNF-α), IL-12, reactive oxygen species (ROS) and inducible nitric oxide synthase (iNOS) 16 . Nonetheless, other mediators, such as IL-4, IL-10 and IL-13, cause macrophages to polarize to the M2 type, which features high release of arginase-1 (Arg-1) and IL-10 to trigger antiinflammatory and immunosuppressive responses 17, 18 . Moreover, macrophage M1/M2 polarization dynamically adapts to changes in the microenvironments, showing macrophage polarization is plastic 19 . Based on research to date, in physiologic synovial joints, macrophages usually remain quiescent along with fibroblasts, whereas they can be polarized into the pro-inflammatory M1 phenotype under OA inflammatory stimulus 20 . Therefore, targeting macrophage polarization during OA onset might emerge as an efficient therapeutic remedy via reversing pro-inflammatory M1 macrophages to the antiinflammatory M2 phenotype, thereby decreasing the expression of detrimental inflammatory stimulus against chondrocytes.
However, only limited reports illustrate effective macrophage targeting strategies during OA treatment. Kinsenoside (Kin) derived from the traditional Chinese medicinal herb Anoectochilus roxburghii is an active small-molecule component used clinically to treat liver disease, hyperglycemia and cancers [21] [22] [23] . Our previous study utilizing microfluidic chips showed that Kin was the most effective anti-inflammatory component in protecting human umbilical vein endothelial cells (HUVECs) from monosodium urate (MSU) crystal damage 11 . However, whether Kin can affect macrophage polarization to inhibit OA progression remains unknown. Hence, we investigated the effects of Kin treatments on M1/M2 macrophage polarization and evaluated the resulting protection of chondrocytes to attenuate OA progression. Additionally, the underlying mechanisms by which Kin repolarizes macrophages and protects chondrocytes were assessed.
Materials and methods

Cells, media and reagents
Primary mouse chondrocytes and RAW264.7 macrophage cell lines were cultured with Dulbecco's minimum essential medium (DMEM; HyClone, Logan, UT, USA) containing 10% fetal bovine serum (Gibco, New York, USA), penicillin at 100 U/mL (Gibco) and streptomycin at 100 μg/mL (Gibco) at 37 1C in humidified conditions with 5% CO 2 . Kin was purchased from Shifeng Biological Technology Company (Shanghai, China). Bacterial LPS of Escherichia coli and recombinant mouse IL-1β, IL-4, and IFN-γ were purchased from PeproTech (Rocky Hill, NJ, USA). IL-1β, IL-6, and TNF-α ELISA kits were purchased from R&D systems (Minneapolis, MN, USA), and iNOS and Arg-1 ELISA kits were purchased from Biovision Inc. (Palo Alto, CA, USA).
Chondrocytes culture and identification
Male C57BL/6J mice were sacrificed and disinfected in 75% alcohol for 10 min. The femur head was exposed under aseptic conditions, and the total articular cartilage was further isolated, collected and cut into 1 mm 3 pieces. The tissue was digested with 0.25% trypsin and 0.2% collagenase II for 30 min and 5 h respectively at 37 1C. Cells were then filtered through a 70 μm cell strainer and washed 3 times with sterile phosphate-buffered saline (PBS). Afterward, the collected chondrocytes were seeded into culturing dishes in DMEM at 37 1C and 5% CO 2 . Culture medium was changed every 2-3 days. Primary chondrocytes were identified by immunofluorescence staining with collagen type II and aggrecan (Santa Cruz, CA, USA) before used in subsequent experiments. Only primary or passaged one generation of chondrocytes were used for experimental procedures. 
Effects of Kin on cell viability
Western blot
Pre-polarized macrophages were treated with various concentrations of Kin. The proteins were extracted and used for Western blot analyses as reported previously 24 .
Macrophage conditioned medium (CM) collection and stimulation
RAW264.7 macrophages were stimulated with LPS plus IFN-γ to display the M1 phenotype and IL-4 for M2 macrophage differentiation for 24 h. Polarized macrophages supernatants were harvested and subjected to centrifugation at a speed of 1000 Â g for 5 min and stored at À80 1C for further experiments. The CM from differentiated macrophages was diluted at the ratio of 1:1 with serum-free medium and added to chondrocytes for further analyses.
Cytokine measurements
Pre-polarized RAW264.7 macrophages were treated with Kin (6.25-25 μg/mL) for 24 h. The CM of macrophages was collected, and the concentrations of IL-1β, IL-6 and TNF-α and iNOS and Arg-1 were measured via ELISA kits according to the manufacturer's guidelines.
Safranin O-fast green (S&F) and toluidine blue staining of chondrocytes
Primary mice chondrocytes (1 Â 10 6 /well) seeded in 6-well plates were cultured in the CM of macrophages for 3 days. Chondrocytes were treated with or without IL-1β (10 ng/mL) and various concentrations of Kin for 24 h. S&F and toluidine blue staining were performed according to the manufacturer's instructions.
Flow cytometry for chondrocyte apoptosis analysis
Chondrocytes (10 6 /well) seeded in 6-well plates were stimulated with or without IL-1β (10 ng/mL) and various concentrations of Kin for 24 h. Chondrocytes in another 6-well plate were treated with CM of macrophages for 3 days. Chondrocyte apoptosis rates were analyzed with annexin V-FITC/propidium iodide (PI) double staining (BD) according to the manufacturer's instructions.
Mice knee OA model induced by anterior cruciate ligament transection (ACLT)
Thirty 2-month-old male C57BL/6J mice were purchased from Shanghai SLAC Laboratory Animal Company (Shanghai, China) and fed on commercial food and provided water in specific pathogen-free conditions approved by the Animal Ethical Committee of Shanghai Ninth People's Hospital. All animal experiments complied with National Institutes of Health guide for the care and use of Laboratory animals. The ACLT-induced abnormal mechanical loading-associated OA of the right knee was established according to previous research 25, 26 . The sham operation was performed by only opening the joint capsule and then suturing the incision. The thirty mice were randomly split into five groups, with six mice per cage. The mice in group 1 mice were treated with the sham operation as the control group. For groups 2-5, ACLT was administered to the right knee of mice. Mice in group 2 were injected intraperitoneally with PBS, and those in groups 3-5 were injected intraperitoneally with Kin at the concentrations of 2.5, 5, and 10 mg/kg body weight every other day for 4 weeks. The concentrations of Kin used in vivo were based on our previous studies 11 .
Evaluations with micro-CT scanning
At 4 weeks post-injections, knee joints of mice were harvested and fixed in 4% paraformaldehyde. Specimens were scanned using micro-CT (μCT 40; Scanco, Zurich, Switzerland) as described previously 27 . We set the scanner at a resolution of 10 μm with voltage, 70 kV; electric current, 114 μA. We defined the region of interest (ROI) to cover the whole subchondral bone in tibial plateaus. Threedimensional structural parameters analyzed included bone volume (BV), bone volume/total tissue volume (BV/TV), and trabecular number (Tb.N), thickness (Tb.Th) and separation (Tb.Sp).
Histological observation
Samples were decalcified in 10% EDTA and then embedded in paraffin. Sagittal sections were cut to a 4 μm thickness of the knee joint medial compartment and processed with hematoxylin & eosin (H&E) and S&F. Osteoarthritis Research Society International (OARSI) and synovitis scores were calculated as previously 28, 29 . (Fig. 1C) . These data showed Kin moderately repolarized M1 macrophages to the M2 phenotype.
Macrophage repolarization by targeting NF-κB and MAPK signals via Kin
Western blot analysis of macrophages revealed that LPSþIFN-γ markedly activated the phosphorylation of IKK, IκBα and p65 in NF-κB signaling. Kin did not affect the expression of phosphorylated IKK in varying groups, whereas the downstream phosphorylation of both IκBα and P65 was inhibited by Kin administration dose-dependently ( Fig. 2A) , indicating that Kin may target IKK-α and IKK-β kinases, further affecting the function of p-IKK. These results are consistent with our previous study in which Kin could bind to specific sites of IKK-α and IKK-β in a molecular docking assay 11 . In the MAPK pathway, phosphorylation of ERK, JNK, and P38 was up-regulated when LPSþIFN-γ was administered; whereas Kin reduced the expression of p-JNK, p-Erk, and p-p38 dose-dependently (Fig. 2B) . Moreover, IL-4, as the mediator of M2 macrophage activation, failed to activate the phosphorylation of kinases in NF-κB/MAPK signaling in comparison with the control group, which indicated that M2 macrophage polarization was not activated by NF-κB/ MAPK signal.
Kin promotes M2 macrophages polarization
Kin increased the expression of M2-related genes Mgl1, Mgl2, Pgc1-β, Arg-1, Il-10 and Cd206 (Fig. 3A) . Immunofluorescence demonstrated the population of CD206 positive macrophages increased after Kin was administered (Fig. 3B) . Furthermore, the percentage of M2 in the IL-4 group was 46.9 7 3.76%, which increased to 48.43 7 3.63%, 55.53 7 3.9%, and 61.7 7 4.25% in the corresponding Kin-treated groups, showing that Kin promoted M2 macrophage polarization (Fig. 3C) . Furthermore, STAT6 is an important transcription factor for M2 polarization 30 , we found that Kin promoted the expression of p-STAT6 in a dose-dependent manner, which could explain how Kin could promote M2 polarization (Fig. 3D) .
Kin prevents impairment of chondrocytes from macrophage CM
ELISA results showed that LPS plus IFN-γ stimulated the expression of IL-6, IL-1β, TNF-α and iNOS in macrophages, signifying that M1-type macrophages could release several destructive factors for subsequent cartilage damage in OA. However, when macrophages were treated with varying concentrations of Kin, the expression of these pro-inflammatory factors decreased significantly, suggesting that the Kin administered targeted M1-type macrophages to reduce relevant releases of destructive factors, thereby providing promising possibilities for subsequent cartilage protection (Fig. 4A) . Hence, we further utilized the CM of macrophages to treat primary chondrocytes. Primary chondrocytes were identified by immunofluorescence for aggrecan (Supporting Information Fig. S2A ) and collagen type II (Supporting Information Fig. S2B ) of mice. Based on the results obtained after 3 days of co-culture, the number of chondrocytes increased with the treatment of Kin compared with that of the LPSþIFN-γ-CM group, as shown by the increase in staining intensity of S&F and toluidine blue staining ( Fig. 4B and C) . Flow cytometry indicated that the apoptosis rate was 19.65 7 0.78% in the LPSþIFN-γ-CM group, which was greater than the 3.41 7 0.78% in the RAW-CM group. In the 6.25, 12.5, and 25 μg/mL Kin-treated groups, the apoptosis rate was significantly (Po0.05) reduced to 11.66 7 1.60%, 9.63 7 2.22%, and 8.89 7 1.92%, respectively, which demonstrated that Kin could exert a dosedependent beneficial effect on macrophage CM-induced chondrocyte apoptosis (Fig. 4D) . Moreover, the observations of chondrocyte viabilities after combined treatments of LPSþIFN-γ-CM with Kin confirmed the result, showing that the cell viabilities of chondrocytes were rescued with Kin administered after LPSþIFN-γ-CM stimulation (Fig. 4E) . These results were also confirmed with Western blotting, which indicated that both the BAX (proapoptotic proteins)/BCL-2 (anti-apoptotic proteins) ratio and the pro-apoptotic proteins cleaved caspase-3/caspase-3 ratio decreased under the treatments with Kin compared with those in the LPSþ IFN-γ-CM group (Fig. 4F) .
Kin inhibits IL-1β-induced chondrocyte apoptosis
The viabilities of chondrocytes were measured after Kin treatments for 2, 24, 48, and 72 h. The results showed that low concentrations of Kin (3.125, 6.25, 12.5, and 25 μg/mL) had minimal inhibitory effects on chondrocytes, whereas concentrations of 100 and 200 μg/mL Kin significantly inhibited cell proliferation at 24, 48, and 72 h. However, 50 μg/mL Kin only inhibited cell proliferation at 72 h (Supporting Information Fig. S3A ). Furthermore, Kin treatments of 6.25, 12.5, and 25 μg/mL obviously protected chondrocytes from IL-1β-induced proliferation inhibition (Fig. S3B) . S&F (Fig. S3C ) and toluidine blue staining (Fig. S3D) showed Kin treatment increased staining intensity compared with that of the IL-1β group, indicating the number of chondrocytes increased with Kin treatment under IL-1β stimulation. Flow cytometry (Fig. 5A ) and caspase-3 activity assay (Fig. 5B ) demonstrated that Kin treatments (6.25-25 μg/mL) exerted beneficial effects on IL-1β-induced chondrocyte apoptosis. In the IL-1β group, the apoptosis rate was 22.23 7 2.03%, which was reduced to 13.47 7 1.40%, 10.38 7 0.90%, and 7.25 7 0.94% in the Kin 6.25, 12.5, and 25 μg/mL treated groups, respectively. These results were also confirmed with Western blotting (Fig. 5C ), which showed both the BAX/BCL-2 ratio and the pro-apoptotic proteins cleaved caspase-3/ caspase-3 ratio increased in the IL-1β group, whereas the ratios decreased in Kin treatment groups dose-dependently. 
Kin reduces IL-1β-induced inflammatory and degenerative cytokines expression in chondrocytes
For mRNA levels, qRT-PCR results showed that IL-1β drastically stimulated the levels of the inflammatory cytokines IL-6, IL-1β, TNF-α, iNOS and COX-2, in addition to varying cartilage destructive factors MMP-3, MMP-13 and ADAMTS5 in chondrocytes. However, IL-1β significantly down-regulated the production of aggrecan, showing that IL-1β could be the primary pathological caused in cartilage destruction during OA development. Nonetheless, we found that Kin treatments (6.25-25 μg/mL) reduced the expression of IL-6, IL-1β, TNF-α, iNOS, COX-2, MMP-3, MMP-13 and ADAMTS5, whereas the expression of the protective aggrecan increased in a dose-dependent manner (Fig. 5D) , demonstrating that Kin could be a potential drug to reduce inflammation and delay degeneration.
Kin decreases bone resorption induced by anterior cruciate ligament transection in vivo
In early stage of OA, bone loss is associated with increased bone remodeling 31 . To investigate the effects of Kin on the subchondral bone remodelling of OA, we administered Kin intraperitoneally in mice after ACLT. Result signified that ACLT injury induced significant bone resorption, as shown by the increased osteolysis in subchondral bone of tibia. Nonetheless, Kin treatments reduced bone loss dose-dependently, showing increased integrity of the knee bone and bone mass in subchondral bone, indicating that osteolysis was diminished after Kin administered in vivo (Fig. 6A  and B) . Statistically, the BV of subchondral bone in tibial plateau was 0.14 7 0.03 mm 3 in the ACLT group, which was significantly (Po0.05) lower than the 0.29 7 0.04 mm 3 of the control group. Nonetheless, in 2.5, 5 and 10 mg/kg Kin-treated mice, BV was 0.15 7 0.04, 0.21 7 0.05, and 0.25 7 0.03 mm 3 , respectively. BV and the other parameters including BV/TV, Tb.N, Tb.Th and Tb. Sp showed the suppressed bone destruction effect of Kin in vivo (Fig. 6C) .
Kin attenuates the progression of OA in ACLT mice
ACLT induced an increase in the thickness of synovial lining cells, whereas Kin reduced dose-dependently the thickness of lining cells and synovial inflammation (Fig. 7A and A1) . Macrophages stained by F4/80 in synovium were increased in the ACLT group, while Kin dose-dependently decreased the infiltration of macrophages (Fig. 7B) . Specifically, we found that the infiltration of pro-inflammatory M1 macrophages (CD16/32 positive cells) in the synovium was increased in the ACLT group, whereas Kin obviously reduced the number of M1 macrophages in Kin-treated OA mice (Fig. 7C) . Additionally, Kin up-regulated the number of M2-type macrophages (CD206 positive cells) in the synovium (Fig. 7D) and decreased the expression of IL-1β and TNF-α in the synovium (Supporting Information Fig. S4A and B) .
S&F and H&E staining demonstrated the loss of proteoglycan and decreased thickness of articular cartilage induced by ACLT surgery. However, in Kin-treated ACLT mice, the degeneration of cartilage was inhibited significantly (Fig. 7E and F) . Moreover, Kin attenuated the loss of aggrecan (Fig. 7G) induced by ACLT, and the expression of cleaved caspase-3, MMP-3, IL-1β and TNF-α were also decreased in articular cartilage after Kin treatment (Fig. S4C-F) . 
Discussion
OA is typically characterized by degeneration and loss of articular cartilage, but involves all tissues of the joint including subchondral bone and synovial membrane 32 . In early stage of OA, bone loss is associated with increased bone remodeling 31 . Increasing evidence showed that osteoclast activity is increased in early OA, disturbing the equilibrium between bone formation and resorption, which could finally lead to a marked reduction in subchondral bone thickness 33, 34 . Furthermore, the reduction in the thickness of the subchondral plate was associated with increased articular cartilage destruction 35 . This progression was followed by slow densification of the subchondral plate and loss of cartilage. In late stage, OA is characterized by decreased bone resorption and development of subchondral sclerosis. With the subchondral plate thickening, increasing loss of aggrecan leads to the reduction of the thickness of non-mineralized articular cartilage 31 . Currently, various therapeutic approaches are applied to treat OA 36 . Despite many studies that attempt to attenuate articular inflammation and delay cartilage degeneration 37 , no effective treatment has yet focused on the vital roles of macrophages during OA development 38 . In this study, we were committed to identify one promising candidate targeting macrophage repolarization for effective OA treatment.
Increasing evidence shows that synovial macrophages are the key effector cells during OA progression 39 . Synovial macrophages promote the production of varying pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α, which further deteriorates synovial inflammation and increases formation of osteophyte 40 . Additionally, macrophages can activate synovial fibroblasts to release destructive enzyme MMPs concomitantly 40 . Therefore, macrophages are realistic to emerge as the novel target for the treatment of OA.
Macrophages express diverse cell surface receptors, which are responsible for the recognition of intercellular signals. These receptors can be triggered by a specific stimulus, which further polarizes macrophages into pro-inflammatory-type M1 or anti-inflammatorytype M2. M1 macrophages highly express MHC II molecules and costimulatory CD80/86 molecules such as CD16/32, CD86 and CD40, which primarily are used to present antigens 41 . M2 macrophages show high expression of phagocytosis markers CD206 and CD163 42 . NF-κB, activator protein-1 (AP-1), and STAT1, among others, are the mediators of M1 macrophage polarization, whereas transcription factors including interferon regulatory factor 4 (IRF4), CCAAT/ enhancer-binding protein β (C/EBP β), STAT6 and peroxisome proliferator-activated receptor γ (PPARγ) can promote M2 activation 43 . NF-κB is an important transcription factor regulating macrophage polarization on exposure to inflammation, infection and stress 44 and also regulates the expression of inflammatory mediators and determines cell differentiation 45 . Our results showed that NF-κB signaling was significantly activated after stimulation with LPS and IFN-γ; whereas Kin dose-dependently inhibited the phosphorylation of IκBα and subsequently P65. The MAPK are a serine-threonine protein kinases family containing p-JNK/JNK, p-ERK/ERK and p-P38/P38, which regulates numerous cellular activities including cell proliferation, differentiation, apoptosis, inflammation, and innate immunity 46 . MAPK signaling is also implicated in modulating the polarization of M1 macrophages 40, 43 , which are important regulators in the production of inflammatory cytokines 47 . Such a signaling pathway can be activated by different cellular stresses such as oxidative and osmotic stress and pro-inflammatory cytokines such as IL-1β. Our results showed that LPS and IFN-γ activated MAPK signaling p-JNK, p-ERK and p-P38, whereas Kin dose-dependently inhibited the activation of MAPK signaling. M2 macrophages are activated by IL-4, IL-10 or IL-13 through the activation of STAT6 48 , which highly express M2 phenotype markers such as CD206 and Arg-1. In the present study, we focused on the effects of Kin on macrophage repolarization and subsequent inflammatory response and found that Kin treatment could repolarize M1 macrophages to the M2 phenotype. Furthermore, we were delighted to discover that Kin could up-regulate the M2 macrophage markers, which might increase M2 macrophage function.
Kin has been found to be a potential immunosuppressive drug which could disrupt dendritic cells (DC)-induced cross-priming of CD8 þ T cell responses in treatment of autoimmune hepatitis (AIH) 49 . Besides, Hsiao et al. 50 demonstrated that Kin increased the population of CD4 þ CD25 þ regulatory T cells, thereby inhibiting the Th1 cell and B cell populations in a collagen-induced arthritis (CIA) model. These signified that Kin is an immunomodulatory drug that could regulate T cells. Furthermore, Kin significantly suppressed TNF-α, IFN-γ, and IL-17 while increase the concentration of IL-10 in the supernatants of splenocytes in CIA mice 50 . As IFN-γ and IL-10 could stimulate macrophage polarization, it can be speculated that Kin may indirectly affect macrophages polarization by affecting regulatory T cells. However, different from RA, OA is mainly caused by mechanical instability, and macrophages in synovial membrane play an important role in the progression of OA. Herein, in this article, we were committed to research whether Kin could directly reprogram pro-inflammatory M1 macrophages to anti-inflammatory M2 phenotype. Whether Kin could regulate macrophage polarization by affecting regulatory T cells in OA is known, this may need to be further studied.
IL-1β is one of the most important pro-inflammatory cytokines in the development of OA, which acts as an injury factor inducing the release of inflammatory mediators and MMPs 51 . In OA joints, excessive production of IL-1β is found in synovial fluid, the synovial membrane, subchondral bone and cartilage 52, 53 . Herein, IL-1β was used as active stimulus to mimic the OA inflammatory microenvironment in vitro. Previous study found that IL-1β activates NF-κB signaling via triggering IκBα phosphorylation 54 . Once activated, P65 dissociates from the inhibitory IκBα complex to enter the cell nucleus, which leads to the transcription of specific targeted genes such as IL-1β, IL-6, and COX-2 55, 56 . Herein, we found that 10 ng/mL IL-1β inhibited chondrocyte proliferation and promoted apoptosis, with increased release of pro-apoptotic proteins such as caspase-3 plus BAX and reduced levels of antiapoptotic protein BCL-2. Moreover, our results showed IL-1β drastically stimulated the levels of inflammatory cytokines IL-6, IL-1β, TNF-α, iNOS, and COX-2 and the expression of cartilage destructive factors MMP-3, MMP-13 and ADAMTS5 in chondrocytes, whereas Kin reduced such inflammation and delayed the following cartilage degeneration. Notably, the production of IL-1β increased under autocrine stimulation, indicating that IL-1β could act as an irritant and product simultaneously during OA progression. Additionally, we found that Kin exerted an anti-apoptotic effect on IL-1β-stimulated chondrocytes, which was most noticeable at the concentration of 25 μg/mL in vitro. Additionally, Kin was administered systemically to target synovial macrophages, which might avoid local infection or septic arthritis caused by repeated intra-articular injection.
Our results showed that Kin played a multifunctional role in the treatment of OA. First, Kin dose-dependently attenuated proinflammatory macrophage release of IL-1β, IL-6, TNF-α, iNOS and IL-12, which were regulated by NF-κB/MAPK signaling 55, 56 .
Even when a certain amount of a cytokine such as IL-1β entered into the joint cavity, Kin directly protected the cartilage from injury. Moreover, Kin reduced the production of COX-2, playing a similar role to that of NSAIDs. Therefore, Kin is a potential substitute for NSAIDs. Further, the damage effect of CM supernatants from pro-inflammatory macrophages was weakened by Kin dose-dependently.
Conclusions
In conclusion, this study demonstrated the positive role of Kin in OA treatment. Kin repolarized M1 macrophages to M2. The potential mechanism was that Kin targeted the NF-κB/MAPK pathway to inhibit the phosphorylation of IκBα, p-JNK, p-ERK, and p-P38 in macrophages, thereby reducing the expression of related inflammatory cytokines. Moreover, Kin attenuated the infiltration of pro-inflammatory M1-type macrophages and articular cartilage degeneration, suggesting that targeting synovial macrophage polarization could be an effective strategy for treating OA. Further, Kin decreased macrophage CM and IL-1β-stimulated chondrocyte apoptosis. The schematic illustration shows the effects of Kin on the M1/M2 macrophage polarization and chondrocytes succinctly. All the results indicate that Kin could be an effective therapeutic candidate for OA treatment.
